• BioRestorative Therapies Inc BRTX.OQ reported a quarterly adjusted loss of 13 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -65 cents. The mean expectation of two analysts for the quarter was for a loss of 43 cents per share. Wall Street expected results to range from -51 cents to -35 cents per share.

• Revenue rose 1,412.4% to $464.30 thousand from a year ago; analysts expected $350.00 thousand.

• BioRestorative Therapies Inc's reported EPS for the quarter was a loss of 13 cents​.

• The company reported a quarterly loss of $1.09 million.

• BioRestorative Therapies Inc shares had fallen by 5.7% this quarter and lost 5.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.1% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for BioRestorative Therapies Inc is 12.00

This summary was machine generated from LSEG data November 13 at 02:25 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)